Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression

The incorporation of peripheral biomarkers in the treatment of major depressive disorders (MDD) could improve the efficiency of treatments and increase remission rate. Peripheral blood mononuclear cells (PBMCs) represent an attractive biological substrate allowing the identification of a drug respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendez-David, Indira, Boursier, Céline, Domergue, Valérie, Colle, Romain, Falissard, Bruno, Corruble, Emmanuelle, Gardier, Alain M., Guilloux, Jean-Philippe, David, Denis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561647/
https://www.ncbi.nlm.nih.gov/pubmed/28860968
http://dx.doi.org/10.3389/fncel.2017.00237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561647/
https://www.ncbi.nlm.nih.gov/pubmed/28860968
http://dx.doi.org/10.3389/fncel.2017.00237

Ejemplares similares